Detalhe da pesquisa
1.
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.
N Engl J Med
; 385(3): 239-250, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34043894
2.
A Bivalent Meningococcal B Vaccine in Adolescents and Young Adults.
N Engl J Med
; 377(24): 2349-2362, 2017 12 14.
Artigo
Inglês
| MEDLINE | ID: mdl-29236639
3.
A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
Pediatr Infect Dis J
; 43(6): 596-603, 2024 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38535409
4.
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
Vaccine
; 39(10): 1534-1543, 2021 03 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33077301
5.
Degree of concordance of Clostridioides difficile strains in adults with community-associated C. difficile infection and infants with C. difficile colonization.
Infect Control Hosp Epidemiol
; 42(6): 731-736, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33208213
6.
Safety and Immunogenicity of a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants in the United States.
Pediatr Infect Dis J
; 40(10): 944-951, 2021 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34525007
7.
Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
Vaccine
; 39(32): 4545-4554, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34215452
8.
Three-Year Follow-up of 2-Dose Versus 3-Dose HPV Vaccine.
Pediatrics
; 147(1)2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33386332
9.
MenACWY-CRM conjugate vaccine booster dose given 4-6â¯years after priming: Results from a phase IIIb, multicenter, open label study in adolescents and adults.
Vaccine
; 37(42): 6171-6179, 2019 09 30.
Artigo
Inglês
| MEDLINE | ID: mdl-31495595
10.
Evaluation of immunogenicity and safety of VARIVAX™ New Seed Process (NSP) in children.
Hum Vaccin Immunother
; 14(2): 442-449, 2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29087781
11.
Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
Vaccine
; 36(35): 5309-5317, 2018 08 23.
Artigo
Inglês
| MEDLINE | ID: mdl-30061029
12.
Development of a novel observer-reported outcome measure for the assessment of Respiratory Syncytial Virus (RSV) infection symptoms in pediatric clinical trials.
J Patient Rep Outcomes
; 2(1): 9, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29757334
13.
Psychometric evaluation of a caregiver diary for the assessment of symptoms of respiratory syncytial virus.
J Patient Rep Outcomes
; 2(1): 10, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-29757327
14.
Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study.
Vaccine
; 34(2): 230-236, 2016 Jan 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26643931
15.
A double blind, randomized, active controlled study to assess the safety, tolerability and immunogenicity of measles, mumps rubella, and varicella vaccine (MMRV) manufactured using an alternative process.
Hum Vaccin Immunother
; 12(8): 2188-2196, 2016 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27149048
16.
Immunogenicity, Tolerability and Safety in Adolescents of Bivalent rLP2086, a Meningococcal Serogroup B Vaccine, Coadministered with Quadrivalent Human Papilloma Virus Vaccine.
Pediatr Infect Dis J
; 35(5): 548-54, 2016 May.
Artigo
Inglês
| MEDLINE | ID: mdl-26835974
17.
M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
Vaccine
; 33(18): 2132-40, 2015 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-25796337
18.
Impact of a birth dose of hepatitis B vaccine on the reactogenicity and immunogenicity of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b combination vaccination.
Pediatr Infect Dis J
; 21(9): 854-9, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12352809
19.
Safety and immunogenicity of an inactivated quadrivalent influenza vaccine in children 6 months through 8 years of age.
Pediatr Infect Dis J
; 33(6): 630-6, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24445833
20.
13-Valent pneumococcal conjugate vaccine in older children and adolescents either previously immunized with or naïve to 7-valent pneumococcal conjugate vaccine.
Pediatr Infect Dis J
; 33(2): 183-9, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24136369